Epirus Biopharmaceuticals Inc buy melinda
Start price
11.11.13
/
50%
€10.18
Target price
12.05.14
€15.00
Performance (%)
-33.30%
End price
12.05.14
€6.79
Summary
This prediction ended on 12.05.14 with a price of €6.79. The BUY prediction by melinda for Epirus Biopharmaceuticals Inc performed very badly with a performance of -33.30%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epirus Biopharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -1.941% | -4.109% | 11.238% | 10.307% |
| iShares Nasdaq 100 | -3.642% | -10.625% | 21.511% | 32.896% |
| iShares Nikkei 225® | -2.728% | -6.434% | 8.146% | 3.246% |
| iShares S&P 500 | -3.440% | -5.152% | 20.197% | 34.290% |
Comments by melinda for this prediction
In the thread Epirus Biopharmaceuticals Inc diskutieren
Biopharma
die Z160 klinischen Studien nicht funktionieren
(Laufzeit überschritten)
Stopped prediction by melinda for Epirus Biopharmaceuticals Inc
Epirus Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.69
02.06.16
02.06.16
€0.90
17.10.16
17.10.16
-81.79%
17.10.16
17.10.16
Epirus Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€52.56
01.10.13
01.10.13
€45.00
08.10.13
08.10.13
0.00%
08.10.13
08.10.13